Robert Moore
Interventional Pain Medicine · The Woodlands, TXNPI 1245241124
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,375 of the $5,430 with a category attached, or 80.6%. 34 manufacturers reported payments, led by Abbott at 39.0% of the total. Reporting peaked in 2020 at $1,824 and has fallen 98.0% since, to $37 in 2023. That places this record below the midpoint for interventional pain medicine clinicians in TX, where the typical reported total is $6,464.
Across 229 payments — averaging $23.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$680
- Collegium Pharmaceutical, Inc.$447
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$268
- Biodelivery Sciences International, Inc.$213
- Amgen$203
- plus $1K from 28 others
What the payments were for
- Consulting fees$1,05019%
- Food & beverage$4,37581%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 56 | $2,120 |
| Boston Scientific | 28 | $680 |
| Collegium Pharmaceutical, Inc. | 33 | $447 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $268 |
| Biodelivery Sciences International, Inc. | 13 | $213 |
| Amgen(2 entities) | 11 | $203 |
| Nevro Corp. | 1 | $140 |
| GRT US Holding, Inc. | 3 | $134 |
| Scilex Pharmaceuticals Inc. | 7 | $117 |
| Sentynl Therapeutics, Inc. | 9 | $112 |
| Acumed LLC | 1 | $104 |
| Fujifilm Sonosite, Inc. | 2 | $92 |
| Daiichi Sankyo Inc. | 5 | $87 |
| Avanos Medical | 4 | $83 |
| IBSA Pharma Inc. | 5 | $75 |
| Zyla Life Sciences, Inc. | 5 | $73 |
| Virtus Pharmaceuticals LLC | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Arbor Pharmaceuticals, Inc. | 3 | $41 |
| Shionogi Inc | 2 | $37 |
| Almatica Pharma LLC | 2 | $30 |
| Medtronic | 1 | $30 |
| Nalu Medical, Inc. | 1 | $28 |
| Johnson & Johnson | 2 | $26 |
| Pacira Therapeutics, Inc. | 1 | $25 |
| Assertio Therapeutics, Inc. | 2 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Pfizer | 2 | $23 |
| Innovation Technologies Inc | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $16 |
| Novartis | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Pernix Therapeutics Holdings, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axium Sheath Braided DRG$1,050
- SUPERION$230
- PROCLAIM$168
- Omnia$140
- Neuromodulation Dspsbls and Accs$117
- ACUMED$104
- Qutenza$102
How this compares
$5,430 in reported general payments places this provider in the 45th percentile of 287 interventional pain medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 56 | $1,020 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in The Woodlands
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.1M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Brian BruelHouston$219K
- Bolkar SahinlerLubbock$188K
- Timothy RatinoFort Worth$139K
- Genaro GutierrezAustin$125K
- Thomas WhiteShenandoah$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.